ATE79268T1 - Vorbeugende und therapeutische mittel fuer zerebrale ischaemie. - Google Patents
Vorbeugende und therapeutische mittel fuer zerebrale ischaemie.Info
- Publication number
- ATE79268T1 ATE79268T1 AT87307383T AT87307383T ATE79268T1 AT E79268 T1 ATE79268 T1 AT E79268T1 AT 87307383 T AT87307383 T AT 87307383T AT 87307383 T AT87307383 T AT 87307383T AT E79268 T1 ATE79268 T1 AT E79268T1
- Authority
- AT
- Austria
- Prior art keywords
- preventive
- therapeutic means
- cerebral ischaemia
- alkyl group
- prophylactic
- Prior art date
Links
- 206010008120 Cerebral ischaemia Diseases 0.000 title abstract 2
- 230000003449 preventive effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 108010024636 Glutathione Proteins 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960003180 glutathione Drugs 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19600686 | 1986-08-20 | ||
| EP87307383A EP0257992B1 (de) | 1986-08-20 | 1987-08-20 | Vorbeugende und therapeutische Mittel für zerebrale Ischämie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE79268T1 true ATE79268T1 (de) | 1992-08-15 |
Family
ID=16350660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87307383T ATE79268T1 (de) | 1986-08-20 | 1987-08-20 | Vorbeugende und therapeutische mittel fuer zerebrale ischaemie. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0257992B1 (de) |
| JP (1) | JPS63152325A (de) |
| KR (1) | KR880002822A (de) |
| AT (1) | ATE79268T1 (de) |
| DE (1) | DE3781064T2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968671A (en) * | 1987-11-26 | 1990-11-06 | Yamanouchi Pharmaceutical Co., Ltd. | Therapeutic agents for ischemic heart diseases |
| US5093478A (en) * | 1989-07-14 | 1992-03-03 | Cornell Research Foundation, Inc. | Preparing glutathione monoesters |
| DE69214467T3 (de) * | 1991-01-10 | 2000-09-28 | Transcend Therapeutics, Inc. | Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom |
| US5747459A (en) * | 1991-02-04 | 1998-05-05 | Nestec, Ltd. | Method for insuring adequate intracellular glutathione in tissue |
| US5095027A (en) * | 1991-02-28 | 1992-03-10 | Clintec Nutrition Co. | Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid |
| US5430045A (en) * | 1992-04-23 | 1995-07-04 | Free Radical Sciences, Inc. | Method of reducing or preventing bone marrow hypoplasia |
| WO1994025052A1 (en) * | 1993-05-03 | 1994-11-10 | Cornell Research Foundation, Inc. | Use of glutathione diesters |
| US5447712A (en) * | 1993-12-09 | 1995-09-05 | Free Radical Sciences | Method of reducing cyclophosphamide induced hemorrhagic cystitis |
| US20060105972A1 (en) | 2004-11-17 | 2006-05-18 | Nagasawa Herbert T | Method to enhance delivery of glutathione and ATP levels in cells |
| TW201201712A (en) | 2010-01-28 | 2012-01-16 | Max International Llc | Compositions comprising sugar-cysteine products |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58215188A (ja) * | 1982-06-07 | 1983-12-14 | Nippon Telegr & Teleph Corp <Ntt> | メモ記入・表示回路 |
| JPS60165883A (ja) * | 1984-02-09 | 1985-08-29 | Matsushita Electric Ind Co Ltd | テレビジヨン信号送受信方法およびテレビジヨン信号受信方法 |
| JPS61179691A (ja) * | 1985-02-05 | 1986-08-12 | Matsushita Graphic Commun Syst Inc | 画像会議システム |
| JPH0783471B2 (ja) * | 1985-06-13 | 1995-09-06 | 株式会社東芝 | 画像通信ネツトワ−ク装置 |
-
1987
- 1987-08-06 JP JP62197598A patent/JPS63152325A/ja active Pending
- 1987-08-19 KR KR870009041A patent/KR880002822A/ko not_active Ceased
- 1987-08-20 EP EP87307383A patent/EP0257992B1/de not_active Expired - Lifetime
- 1987-08-20 DE DE8787307383T patent/DE3781064T2/de not_active Expired - Lifetime
- 1987-08-20 AT AT87307383T patent/ATE79268T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0257992A3 (en) | 1989-10-25 |
| JPS63152325A (ja) | 1988-06-24 |
| KR880002822A (ko) | 1988-05-11 |
| EP0257992B1 (de) | 1992-08-12 |
| EP0257992A2 (de) | 1988-03-02 |
| DE3781064T2 (de) | 1992-12-17 |
| DE3781064D1 (de) | 1992-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO303221B1 (no) | Hydroksaminsyrederivater | |
| ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
| DE3781064D1 (de) | Vorbeugende und therapeutische mittel fuer zerebrale ischaemie. | |
| IL88303A (en) | Derivatives of 6-fluoro-7-û4-( (5-methyl-2-oxo-1,3- dioxolen-4-yl)methyl) piperazin-1-ylù-4 (1h)-oxo-1,3-thiazeto(3,2-a) quinoline-3-carboxylic acid | |
| DE69921151D1 (de) | Fluorszierende marker | |
| ATE399545T1 (de) | Mittel zur verringerung der eigeweidefette | |
| DK0420121T3 (da) | Antitumormiddel | |
| DK0934939T3 (da) | Neuraminsyreforbinelser | |
| NO168421C (no) | Analogifremgangsmaate ved fremstilling av antiarytmiske midler | |
| ATE320417T1 (de) | Naphthimidobenzamid-derivate | |
| ATE274903T1 (de) | Antivirale mittel | |
| DE3862791D1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
| EA200100967A1 (ru) | Новое иммунодепрессивное средство | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| IE873442L (en) | Cephalosporin derivative | |
| DK0580378T3 (da) | Substituerede benzoatderivater | |
| DE69012845D1 (de) | Exo-3'-4'-O-benzyliden-3"-demethylchartreusin und seine Salze. | |
| ATE141918T1 (de) | Isoquinolinderivate | |
| DK348389A (da) | Phenylpropenderivater | |
| ES2040223T3 (es) | Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion. | |
| EA200000300A1 (ru) | Способ получения аминокарбонильных производных генезеролина, обладающих селективной в отношении головного мозга антихолинэстеразной активностью |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |